Immunogenicity of BNT162b2 in children 6 months to under 5 years of age with previous SARS-CoV-2 infection, in the era of Omicron predominance

BACKGROUND: Children 6 months to < 5 years old are recommended to receive 3-dose regimen of BNT162b2. Children previously infected with Omicron variant of SARS-CoV-2 develop immunity from natural infection, therefore may require fewer doses of vaccine. OBJECTIVE: To compare immunogenicity of 1- o...

Descripción completa

Detalles Bibliográficos
Autores principales: Nantanee, Rapisa, Jaru-Ampornpan, Peera, Chantasrisawad, Napaporn, Himananto, Orawan, Papakhee, Supawan, Sophonphan, Jiratchaya, Tawan, Monta, Jupimai, Thidarat, Anugulruengkitt, Suvaporn, Puthanakit, Thanyawee
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Regular paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10432840/
https://www.ncbi.nlm.nih.gov/pubmed/37601322
http://dx.doi.org/10.1016/j.jvacx.2023.100367

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10432840/
https://www.ncbi.nlm.nih.gov/pubmed/37601322
http://dx.doi.org/10.1016/j.jvacx.2023.100367

Ejemplares similares